Table of Contents (574)
Contents - Inhalt - Sommaire
Editorial (576)
Editorial
Scientific Articles (577)
Molecular Informatics as an Enabling in silico Technology Platform for Drug Discovery
E. Jacoby*, A. Schuffenhauer, M. Popov, K. Azzaoui, E. Vangrevelinghe, J. Priestle, P. Ferrara, B. Faller, P. Acklin
Scientific Articles (588)
Lead Generation: Sowing the Seeds for Future Success
K.H. Bleicher, M. Nettekoven, J.-U. Peters, R. Wyler*
Scientific Articles (601)
Small Molecule Drug Discovery in the Fast-Changing World of Biotechnology
S. Halazy, M.K. Schwarz*
Scientific Articles (608)
Drug Discovery in Oncology
C. García-Echeverría
Scientific Articles (613)
5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures
D. Adams, A. Bénardeau, M.J. Bickerdike, J.M. Bentley, C. Bissantz, A. Bourson, I.A. Cliffe, P. Hebeisen, G.A. Kennett, A.R. Knight, C.S. Malcolm, J. Mizrahi, J.-M. Plancher*, H. Richter, S. Röver, S. Taylor, S.P. Vickers
Scientific Articles (621)
The Synthetic Development of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu®): A Challenge for Synthesis & Process Research
S. Abrecht, P. Harrington, H. Iding, M. Karpf*, R. Trussardi, B. Wirz, U. Zutter
Scientific Articles (630)
2-Styryl-pyridines and 2-(3,4-Dihydro-naphthalen-2-yl)-pyridines as Potent NR1/2B Subtype Selective NMDA Receptor Antagonists
B. Buettelmann*, A. Alanine, A. Bourson, R. Gill, M.-P. Heitz, V. Mutel, E. Pinard, G. Trube, R. Wyler
Scientific Articles (634)
Inhibitors of Plasmepsin II – Potential Antimalarial Agents
C. Boss*, S. Richard-Bildstein, R. Furnari, J.-M. Bourgeois, O. Corminboeuf, C. Grisostomi, L. Coppex, L. Harris, L. Prade, S. Meyer, C. Binkert, W. Fischli, R. Brun, T. Weller
Scientific Articles (640)
Broad Spectrum Chemistry as Practised by Novartis Process Research
S.J. Mickel*, R. Fischer, W. Marterer
News & Events (664)
Var. Informations
Chimia Report (667)
CHIMIA-Report, 2004/09